Asarfi Hospital announced robust Q1 FY27 financial results.

Consolidated revenue grew 33% year-over-year to ₹47.34 Cr, achieving an EBITDA margin of 20% and a PAT margin of 9%. Profit after tax increased to ₹4.27 Cr from ₹3.12 Cr in the prior year.

This strong performance was driven by improved patient realizations, enhanced average revenue per operating bed, and a richer casemix.

Both inpatient and outpatient revenues saw significant growth, supported by higher patient volumes and a strong showing in high-acuity specialties including Cardiology and Oncology.

The Board of Directors approved the unaudited financial results for the quarter.